p53 downregulates CRKL oncogene through miR-200

被引：0
|
作者：
Tokino, Takashi
Tamura, Miyuki
Idogawa, Masashi
Sasaki, Yasushi
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3687
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3687
引用
收藏
页数：3
相关论文
共 50 条
  • [31] MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage
    Hsu, Hsin-Ling
    Choy, Chik On
    Kasiappan, Ravi
    Shih, Hung-Ju
    Sawyer, Jeffrey R.
    Shu, Chung-Li
    Chu, Kang-Lin
    Chen, Yi-Rong
    Hsu, Hsin-Fen
    Gartenhaus, Ronald B.
    DNA REPAIR, 2007, 6 (09) : 1319 - 1332
  • [32] MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
    N Wu
    X Lin
    X Zhao
    L Zheng
    L Xiao
    J Liu
    L Ge
    S Cao
    British Journal of Cancer, 2013, 109 : 2853 - 2863
  • [33] MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
    Wu, N.
    Lin, X.
    Zhao, X.
    Zheng, L.
    Xiao, L.
    Liu, J.
    Ge, L.
    Cao, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (11) : 2853 - 2863
  • [34] miR-200 family promotes podocyte differentiation through repression of RSAD2
    Zhigui Li
    Hongqiang Yin
    Shuang Hao
    Lifeng Wang
    Jing Gao
    Xiaoyue Tan
    Zhuo Yang
    Scientific Reports, 6
  • [35] miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
    Gao, Yu
    Zhang, Wenzhi
    Liu, Chengwen
    Li, Guanghua
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [36] Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
    S Masciarelli
    G Fontemaggi
    S Di Agostino
    S Donzelli
    E Carcarino
    S Strano
    G Blandino
    Oncogene, 2014, 33 : 1601 - 1608
  • [37] Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
    Masciarelli, S.
    Fontemaggi, G.
    Di Agostino, S.
    Donzelli, S.
    Carcarino, E.
    Strano, S.
    Blandino, G.
    ONCOGENE, 2014, 33 (12) : 1601 - 1608
  • [38] The Contrived Mutant p53 Oncogene - Beyond Loss of Functions
    Sabapathy, Kanaga
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [39] EXPRESSION OF THE P53 ONCOGENE IN ACUTE MYELOBLASTIC-LEUKEMIA
    SMITH, LJ
    BENCHIMOL, S
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 444 - 444
  • [40] Oncogene-mediated regulation of p53 ISGylation and functions
    Huang, Yi-Fu
    Bulavin, Dmitry V.
    ONCOTARGET, 2014, 5 (14) : 5808 - 5818
12345